The importance of microjet vs shock wave formation in sonophoresis

Journal of Controlled Release

Volumn 148, Issue 2, 2010, Pages 204-211

  Wolloch, Lior ^a   Kost, Joseph ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cavitations; Microjets; Shock waves; Sonophoresis; Transdermal; Ultrasound

Indexed keywords

DIRECT AND INDIRECT METHODS; INERTIAL CAVITATION; LOCALIZED TRANSPORT REGIONS; LOW-FREQUENCY ULTRASOUND; MASS TRANSPORT; MICRO JET; PERMEABILITY ENHANCEMENT; SKIN PERMEABILITY; SONOPHORESIS; STRATUM CORNEUM; TRANSDERMAL; TRANSDERMAL DRUG DELIVERY; ULTRASOUND; WAVE FORMATION;

CAVITATION; CONTROLLED DRUG DELIVERY; SHOCK WAVES; ULTRASONICS;

WAVES;

ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DYNAMICS; ECHOGRAPHY; MICROJET; NONHUMAN; PRIORITY JOURNAL; SHOCK WAVE; SKIN PERMEABILITY; SONOPHORESIS; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; HIGH-ENERGY SHOCK WAVES; MICROBUBBLES; PARTICLE SIZE; PERMEABILITY; PHONOPHORESIS; SKIN; SKIN ABSORPTION; SWINE; TEMPERATURE; ULTRASONICS;

EID: 78649330180     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.07.106     Document Type: Article

References (40)

1. Mitragotri S. Breaking the skin barrier. Adv. Drug Deliv. Rev. 2004, 56:555-556.
2. Prausnitz M.R., Mitragotri S., Langer R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 2004, 3:115-124.
3. Lavon I., Kost J. Ultrasound and transdermal drug delivery. Drug Discov. Today 2004, 9:670-676.
4. Kost J., Wolloch L. Ultrasound in percutaneous absorption. Enhancement in Drug Delivery 2006, 317-330. CRC Press. E. Touitou, B.W. Barry (Eds.).
5. FDA, http://www.accessdata.fda.gov/cdrh_docs/pdf4/K040525.pdf.
6. Ogura M., Paliwal S., Mitragotri S. Low-frequency sonophoresis: current status and future prospects. Adv. Drug Deliv. Rev. 2008, 60:1218-1223.
7. Tezel A., Sens A., Tuchscherer J., Mitragotri S. Frequency dependence of sonophoresis. Pharm. Res. 2001, 18:1694-1700.
8. Kushner J., Blankschtein D., Langer R. Heterogeneity in skin treated with low-frequency ultrasound. J. Pharm. Sci. 2008, 97:4119-4128.
9. Kushner J., Blankschtein D., Langer R. Evaluation of hydrophilic permeant transport parameters in the localized and non-localized transport regions of skin treated simultaneously with low-frequency ultrasound and sodium lauryl sulfate. J. Pharm. Sci. 2008, 97:906-918.
10. Kushner J., Kim D., So P.T., Blankschtein D., Langer R.S. Dual-channel two-photon microscopy study of transdermal transport in skin treated with low-frequency ultrasound and a chemical enhancer. J. Invest. Dermatol. 2007, 127:2832-2846.
11. Paliwal S., Menon G.K., Mitragotri S. Low-frequency sonophoresis: ultrastructural basis for stratum corneum permeability assessed using quantum dots. J. Invest. Dermatol. 2006, 126:1095-1101.
12. Tezel A., Dokka S., Kelly S., Hardee G.E., Mitragotri S. Topical delivery of anti-sense oligonucleotides using low-frequency sonophoresis. Pharm. Res. 2004, 21:2219-2225.
13. Alvarez-Roman R., Merino G., Kalia Y.N., Naik A., Guy R.H. Skin permeability enhancement by low frequency sonophoresis: lipid extraction and transport pathways. J. Pharm. Sci. 2003, 92:1138-1146.
14. Tezel A., Sens A., Tuchscherer J., Mitragotri S. Synergistic effect of low-frequency ultrasound and surfactants on skin permeability. J. Pharm. Sci. 2002, 91:91-100.
15. Kushner J., Blankschtein D., Langer R. Experimental demonstration of the existence of highly permeable localized transport regions in low-frequency sonophoresis. J. Pharm. Sci. 2004, 93:2733-2745.
16. Tezel A., Mitragotri S. Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. Biophys. J. 2003, 85:3502-3512.
17. Lauterborn W., Ohl C. Cavitation bubble dynamics. Ultrason. Sonochem. 1997, 4:65-75.
18. Suslick K.S. Sonoluminescence and sonochemistry. Encyclopedia of Physical Science and Technology 2001, 363-376. Academic Press Inc., San Diego. R.A. Meyers (Ed.).
19. Suslick K.S. Sonochemistry. Science 1990, 247:1439-1445.
20. Doktycz S.J., Suslick K.S. Interparticle collisions driven by ultrasound. Science 1990, 247:1067-1069.
21. Terahara T., Mitragotri S., Kost J., Langer R. Dependence of low-frequency sonophoresis on ultrasound parameters; distance of the horn and intensity. Int. J. Pharm. 2002, 235:35-42.
22. Tezel A., Sens A., Mitragotri S. Description of transdermal transport of hydrophilic solutes during low-frequency sonophoresis based on a modified porous pathway model. J. Pharm. Sci. 2003, 92:381-393.
23. Mitragotri S., Ray D., Farrell J., Tang H., Yu B., Kost J., Blankschtein D., Langer R. Synergistic effect of low-frequency ultrasound and sodium lauryl sulfate on transdermal transport. J. Pharm. Sci. 2000, 89:892-900.
24. Lavon I., Grossman N., Kost J. The nature of ultrasound-SLS synergism during enhanced transdermal transport. J. Control. Release 2005, 107:484-494.
25. Lavon I., Grossman N., Kost J., Kimmel E., Enden G. Bubble growth within the skin by rectified diffusion might play a significant role in sonophoresis. J. Control. Release 2007, 117:246-255.
26. Akomeah F., Nazir T., Martin G.P., Brown M.B. Effect of heat on the percutaneous absorption and skin retention of three model penetrants. Eur. J. Pharm. Sci. 2004, 21:337-345.
27. Mitragotri S., Blankschtein D., Langer R. Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res. 1996, 13:411-420.
28. Katz N.P., Shapiro D.E., Herrmann T.E., Kost J., Custer L.M. Rapid onset of cutaneous anesthesia with EMLA cream after pretreatment with a new ultrasound-emitting device. Anesth. Analg. 2004, 98:371-376.
29. Boucaud A., Machet L., Arbeille B., Machet M.C., Sournac M., Mavon A., Patat F., Vaillant L. In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin. Int. J. Pharm. 2001, 228:69-77.
30. Mitragotri S., Kost J. Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound. Pharm. Res. 2001, 18:1151-1156.
31. Tang H., Blankschtein D., Langer R. Effects of low-frequency ultrasound on the transdermal permeation of mannitol: comparative studies with in vivo and in vitro skin. J. Pharm. Sci. 2002, 91:1776-1794.
32. Eddingsaas N.C., Suslick K.S. Evidence for a plasma core during multibubble sonoluminescence in sulfuric acid. J. Am. Chem. Soc. 2007, 129:3838-3839.
33. Nightingale K.R., Kornguth P.J., Trahey G.E. The use of acoustic streaming in breast lesion diagnosis: a clinical study. Ultrasound Med. Biol. 1999, 25:75-87.
34. Mitragotri S., Blankschtein D., Langer R. Ultrasound-mediated transdermal protein delivery. Science 1995, 269:850-853.
35. Mitragotri S., Blankschtein D., Langer R. Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res. 1996, 13:411-420.
36. Mitragotri S., Edwards D.A., Blankschtein D., Langer R. A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J. Pharm. Sci. 1995, 84:697-706.
37. Merino G., Kalia Y.N., Delgado-Charro M.B., Potts R.O., Guy R.H. Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis. J. Control. Release 2003, 88:85-94.
38. Mason T.J. Introduction. Chemistry with Ultrasound 1990, 8-10. Elsevier Applied Science, London and New York. T.J. Mason (Ed.).
39. Boucaud A., Montharu J., Machet L., Arbeille B., Machet M.C., Patat F., Vaillant L. Clinical, histologic, and electron microscopy study of skin exposed to low-frequency ultrasound. Anat. Rec. 2001, 264:114-119.
40. Kost J., Mitragotri S., Gabbay R.A., Pishko M., Langer R. Transdermal monitoring of glucose and other analytes using ultrasound. Nat. Med. 2000, 6:347-350.